nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—autistic disorder—Clonazepam—epilepsy syndrome	0.0396	0.144	CpDpCtD
Quetiapine—CHRM3—epilepsy syndrome	0.0368	0.18	CbGaD
Quetiapine—CHRM1—epilepsy syndrome	0.0343	0.168	CbGaD
Quetiapine—bipolar disorder—Lamotrigine—epilepsy syndrome	0.0314	0.114	CpDpCtD
Quetiapine—bipolar disorder—Oxcarbazepine—epilepsy syndrome	0.0314	0.114	CpDpCtD
Quetiapine—CHRM2—epilepsy syndrome	0.028	0.137	CbGaD
Quetiapine—HTR7—epilepsy syndrome	0.0279	0.137	CbGaD
Quetiapine—bipolar disorder—Topiramate—epilepsy syndrome	0.0267	0.0968	CpDpCtD
Quetiapine—ADRA2A—epilepsy syndrome	0.0239	0.117	CbGaD
Quetiapine—bipolar disorder—Carbamazepine—epilepsy syndrome	0.0238	0.0863	CpDpCtD
Quetiapine—schizophrenia—Lamotrigine—epilepsy syndrome	0.0227	0.0823	CpDpCtD
Quetiapine—Amoxapine—Diazepam—epilepsy syndrome	0.0215	0.132	CrCrCtD
Quetiapine—bipolar disorder—Valproic Acid—epilepsy syndrome	0.0202	0.0734	CpDpCtD
Quetiapine—bipolar disorder—Clonazepam—epilepsy syndrome	0.019	0.069	CpDpCtD
Quetiapine—Loxapine—Clobazam—epilepsy syndrome	0.0184	0.113	CrCrCtD
Quetiapine—CYP2C19—epilepsy syndrome	0.0173	0.0847	CbGaD
Quetiapine—Clozapine—Clonazepam—epilepsy syndrome	0.0173	0.106	CrCrCtD
Quetiapine—schizophrenia—Carbamazepine—epilepsy syndrome	0.0172	0.0624	CpDpCtD
Quetiapine—Loxapine—Diazepam—epilepsy syndrome	0.0171	0.105	CrCrCtD
Quetiapine—Clozapine—Clobazam—epilepsy syndrome	0.0158	0.0969	CrCrCtD
Quetiapine—bipolar disorder—Gabapentin—epilepsy syndrome	0.0153	0.0556	CpDpCtD
Quetiapine—Clozapine—Diazepam—epilepsy syndrome	0.0147	0.0901	CrCrCtD
Quetiapine—schizophrenia—Valproic Acid—epilepsy syndrome	0.0146	0.053	CpDpCtD
Quetiapine—HTR2A—epilepsy syndrome	0.014	0.0687	CbGaD
Quetiapine—Methdilazine—Carbamazepine—epilepsy syndrome	0.0138	0.0848	CrCrCtD
Quetiapine—schizophrenia—Clonazepam—epilepsy syndrome	0.0138	0.0499	CpDpCtD
Quetiapine—CYP2D6—epilepsy syndrome	0.0128	0.0628	CbGaD
Quetiapine—Methdilazine—Oxcarbazepine—epilepsy syndrome	0.0127	0.0781	CrCrCtD
Quetiapine—Promazine—Carbamazepine—epilepsy syndrome	0.011	0.0677	CrCrCtD
Quetiapine—Prochlorperazine—Clobazam—epilepsy syndrome	0.0106	0.0647	CrCrCtD
Quetiapine—Promazine—Oxcarbazepine—epilepsy syndrome	0.0102	0.0624	CrCrCtD
Quetiapine—ABCB1—epilepsy syndrome	0.00915	0.0448	CbGaD
Quetiapine—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00641	0.0377	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00537	0.0315	CbGbCtD
Quetiapine—CYP3A7—Carbamazepine—epilepsy syndrome	0.00537	0.0315	CbGbCtD
Quetiapine—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00517	0.0304	CbGbCtD
Quetiapine—CYP3A7—Phenytoin—epilepsy syndrome	0.00481	0.0283	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00481	0.0283	CbGbCtD
Quetiapine—CYP2C19—Felbamate—epilepsy syndrome	0.00481	0.0283	CbGbCtD
Quetiapine—CYP2C19—Trimethadione—epilepsy syndrome	0.00481	0.0283	CbGbCtD
Quetiapine—ABCB1—Levetiracetam—epilepsy syndrome	0.00456	0.0268	CbGbCtD
Quetiapine—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00452	0.0266	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00429	0.0252	CbGbCtD
Quetiapine—CYP3A7—Phenobarbital—epilepsy syndrome	0.00429	0.0252	CbGbCtD
Quetiapine—CYP3A7—Midazolam—epilepsy syndrome	0.00423	0.0249	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00423	0.0249	CbGbCtD
Quetiapine—CYP3A7—Diazepam—epilepsy syndrome	0.00407	0.0239	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00407	0.0239	CbGbCtD
Quetiapine—CYP3A5—Carbamazepine—epilepsy syndrome	0.00403	0.0237	CbGbCtD
Quetiapine—CYP2C19—Clobazam—epilepsy syndrome	0.00392	0.023	CbGbCtD
Quetiapine—CYP3A5—Phenytoin—epilepsy syndrome	0.00361	0.0212	CbGbCtD
Quetiapine—CYP2C19—Carbamazepine—epilepsy syndrome	0.00325	0.0191	CbGbCtD
Quetiapine—CYP3A5—Phenobarbital—epilepsy syndrome	0.00322	0.0189	CbGbCtD
Quetiapine—CYP3A5—Midazolam—epilepsy syndrome	0.00317	0.0187	CbGbCtD
Quetiapine—ABCB1—Clobazam—epilepsy syndrome	0.00316	0.0186	CbGbCtD
Quetiapine—CYP3A5—Diazepam—epilepsy syndrome	0.00305	0.0179	CbGbCtD
Quetiapine—ABCB1—Lamotrigine—epilepsy syndrome	0.00304	0.0179	CbGbCtD
Quetiapine—CYP2C19—Primidone—epilepsy syndrome	0.00303	0.0178	CbGbCtD
Quetiapine—CYP2C19—Phenytoin—epilepsy syndrome	0.00291	0.0171	CbGbCtD
Quetiapine—CYP2C19—Propofol—epilepsy syndrome	0.00272	0.016	CbGbCtD
Quetiapine—ABCB1—Carbamazepine—epilepsy syndrome	0.00262	0.0154	CbGbCtD
Quetiapine—CYP2C19—Phenobarbital—epilepsy syndrome	0.0026	0.0153	CbGbCtD
Quetiapine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0025	0.0147	CbGbCtD
Quetiapine—CYP2C19—Diazepam—epilepsy syndrome	0.00246	0.0145	CbGbCtD
Quetiapine—CYP3A5—Valproic Acid—epilepsy syndrome	0.0024	0.0141	CbGbCtD
Quetiapine—CYP2C19—Zonisamide—epilepsy syndrome	0.0024	0.0141	CbGbCtD
Quetiapine—ABCB1—Phenytoin—epilepsy syndrome	0.00235	0.0138	CbGbCtD
Quetiapine—CYP3A4—Felbamate—epilepsy syndrome	0.00232	0.0137	CbGbCtD
Quetiapine—CYP3A4—Trimethadione—epilepsy syndrome	0.00232	0.0137	CbGbCtD
Quetiapine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00218	0.0128	CbGbCtD
Quetiapine—ABCB1—Phenobarbital—epilepsy syndrome	0.00209	0.0123	CbGbCtD
Quetiapine—ABCB1—Midazolam—epilepsy syndrome	0.00206	0.0121	CbGbCtD
Quetiapine—CYP2D6—Propofol—epilepsy syndrome	0.00206	0.0121	CbGbCtD
Quetiapine—ABCB1—Diazepam—epilepsy syndrome	0.00199	0.0117	CbGbCtD
Quetiapine—CYP3A4—Clonazepam—epilepsy syndrome	0.00198	0.0116	CbGbCtD
Quetiapine—CYP2C19—Valproic Acid—epilepsy syndrome	0.00194	0.0114	CbGbCtD
Quetiapine—HTR1D—meninx—epilepsy syndrome	0.00194	0.0614	CbGeAlD
Quetiapine—CYP3A4—Clobazam—epilepsy syndrome	0.00189	0.0111	CbGbCtD
Quetiapine—CYP2C19—Topiramate—epilepsy syndrome	0.00175	0.0103	CbGbCtD
Quetiapine—CYP3A4—Rufinamide—epilepsy syndrome	0.00161	0.00947	CbGbCtD
Quetiapine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00157	0.00923	CbGbCtD
Quetiapine—CYP3A4—Primidone—epilepsy syndrome	0.00147	0.00861	CbGbCtD
Quetiapine—CYP3A4—Phenytoin—epilepsy syndrome	0.00141	0.00828	CbGbCtD
Quetiapine—CYP3A4—Propofol—epilepsy syndrome	0.00131	0.00772	CbGbCtD
Quetiapine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00125	0.00738	CbGbCtD
Quetiapine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00125	0.00738	CbGbCtD
Quetiapine—CYP3A4—Midazolam—epilepsy syndrome	0.00124	0.00727	CbGbCtD
Quetiapine—CYP3A4—Diazepam—epilepsy syndrome	0.00119	0.00699	CbGbCtD
Quetiapine—CYP3A4—Zonisamide—epilepsy syndrome	0.00116	0.00683	CbGbCtD
Quetiapine—HTR2A—phrenic nerve—epilepsy syndrome	0.00104	0.033	CbGeAlD
Quetiapine—CYP3A4—Valproic Acid—epilepsy syndrome	0.000938	0.00551	CbGbCtD
Quetiapine—HTR3A—vagus nerve—epilepsy syndrome	0.000884	0.028	CbGeAlD
Quetiapine—CYP3A4—Topiramate—epilepsy syndrome	0.000846	0.00497	CbGbCtD
Quetiapine—DRD3—telencephalic ventricle—epilepsy syndrome	0.000792	0.025	CbGeAlD
Quetiapine—HTR7—locus ceruleus—epilepsy syndrome	0.000747	0.0236	CbGeAlD
Quetiapine—HTR7—vagus nerve—epilepsy syndrome	0.000572	0.0181	CbGeAlD
Quetiapine—DRD1—telencephalic ventricle—epilepsy syndrome	0.000567	0.0179	CbGeAlD
Quetiapine—HTR6—ganglion—epilepsy syndrome	0.000474	0.015	CbGeAlD
Quetiapine—HTR2A—locus ceruleus—epilepsy syndrome	0.000466	0.0147	CbGeAlD
Quetiapine—DRD5—ganglion—epilepsy syndrome	0.000462	0.0146	CbGeAlD
Quetiapine—HTR1B—telencephalic ventricle—epilepsy syndrome	0.000459	0.0145	CbGeAlD
Quetiapine—HTR1D—telencephalic ventricle—epilepsy syndrome	0.000445	0.0141	CbGeAlD
Quetiapine—HTR2C—telencephalic ventricle—epilepsy syndrome	0.00044	0.0139	CbGeAlD
Quetiapine—HTR7—pons—epilepsy syndrome	0.00043	0.0136	CbGeAlD
Quetiapine—HTR7—autonomic nervous system—epilepsy syndrome	0.000397	0.0126	CbGeAlD
Quetiapine—HTR2A—cerebellar cortex—epilepsy syndrome	0.00038	0.012	CbGeAlD
Quetiapine—HTR1A—telencephalic ventricle—epilepsy syndrome	0.000371	0.0117	CbGeAlD
Quetiapine—HTR2A—vagus nerve—epilepsy syndrome	0.000357	0.0113	CbGeAlD
Quetiapine—HTR7—telencephalic ventricle—epilepsy syndrome	0.000354	0.0112	CbGeAlD
Quetiapine—DRD1—ganglion—epilepsy syndrome	0.000353	0.0112	CbGeAlD
Quetiapine—HTR3A—ganglion—epilepsy syndrome	0.000341	0.0108	CbGeAlD
Quetiapine—DRD2—telencephalic ventricle—epilepsy syndrome	0.000335	0.0106	CbGeAlD
Quetiapine—HTR1B—ganglion—epilepsy syndrome	0.000286	0.00904	CbGeAlD
Quetiapine—HTR1D—ganglion—epilepsy syndrome	0.000277	0.00875	CbGeAlD
Quetiapine—HTR2C—ganglion—epilepsy syndrome	0.000274	0.00867	CbGeAlD
Quetiapine—HTR2A—pons—epilepsy syndrome	0.000268	0.00849	CbGeAlD
Quetiapine—HTR1E—brainstem—epilepsy syndrome	0.000263	0.00831	CbGeAlD
Quetiapine—HTR1E—forebrain—epilepsy syndrome	0.000254	0.00802	CbGeAlD
Quetiapine—HTR2A—autonomic nervous system—epilepsy syndrome	0.000248	0.00783	CbGeAlD
Quetiapine—HTR1E—telencephalon—epilepsy syndrome	0.000233	0.00738	CbGeAlD
Quetiapine—HTR1A—ganglion—epilepsy syndrome	0.000231	0.0073	CbGeAlD
Quetiapine—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000221	0.00699	CbGeAlD
Quetiapine—HTR7—ganglion—epilepsy syndrome	0.00022	0.00697	CbGeAlD
Quetiapine—DRD2—ganglion—epilepsy syndrome	0.000208	0.00659	CbGeAlD
Quetiapine—HTR6—forebrain—epilepsy syndrome	0.000199	0.00629	CbGeAlD
Quetiapine—DRD5—forebrain—epilepsy syndrome	0.000194	0.00613	CbGeAlD
Quetiapine—HTR6—telencephalon—epilepsy syndrome	0.000183	0.00579	CbGeAlD
Quetiapine—DRD5—telencephalon—epilepsy syndrome	0.000178	0.00563	CbGeAlD
Quetiapine—HTR1A—hindbrain—epilepsy syndrome	0.000175	0.00553	CbGeAlD
Quetiapine—HTR7—hindbrain—epilepsy syndrome	0.000167	0.00529	CbGeAlD
Quetiapine—ADRA1A—hindbrain—epilepsy syndrome	0.000161	0.0051	CbGeAlD
Quetiapine—DRD2—hindbrain—epilepsy syndrome	0.000158	0.005	CbGeAlD
Quetiapine—ADRA1D—forebrain—epilepsy syndrome	0.000155	0.00491	CbGeAlD
Quetiapine—DRD1—brainstem—epilepsy syndrome	0.000153	0.00485	CbGeAlD
Quetiapine—H1F0—forebrain—epilepsy syndrome	0.00015	0.00474	CbGeAlD
Quetiapine—HTR3A—brainstem—epilepsy syndrome	0.000148	0.00469	CbGeAlD
Quetiapine—DRD1—forebrain—epilepsy syndrome	0.000148	0.00468	CbGeAlD
Quetiapine—HTR1E—head—epilepsy syndrome	0.000145	0.00459	CbGeAlD
Quetiapine—HTR3A—forebrain—epilepsy syndrome	0.000143	0.00452	CbGeAlD
Quetiapine—ADRA1D—telencephalon—epilepsy syndrome	0.000143	0.00452	CbGeAlD
Quetiapine—H1F0—telencephalon—epilepsy syndrome	0.000138	0.00436	CbGeAlD
Quetiapine—HTR1E—nervous system—epilepsy syndrome	0.000138	0.00435	CbGeAlD
Quetiapine—HTR2A—ganglion—epilepsy syndrome	0.000137	0.00435	CbGeAlD
Quetiapine—DRD1—telencephalon—epilepsy syndrome	0.000136	0.00431	CbGeAlD
Quetiapine—HTR1E—central nervous system—epilepsy syndrome	0.000133	0.00419	CbGeAlD
Quetiapine—HTR3A—telencephalon—epilepsy syndrome	0.000131	0.00416	CbGeAlD
Quetiapine—CHRM4—head—epilepsy syndrome	0.000127	0.00403	CbGeAlD
Quetiapine—HTR1B—brainstem—epilepsy syndrome	0.000124	0.00393	CbGeAlD
Quetiapine—DRD4—brain—epilepsy syndrome	0.000122	0.00386	CbGeAlD
Quetiapine—CHRM4—nervous system—epilepsy syndrome	0.000121	0.00382	CbGeAlD
Quetiapine—HTR1D—brainstem—epilepsy syndrome	0.00012	0.00381	CbGeAlD
Quetiapine—HTR1B—forebrain—epilepsy syndrome	0.00012	0.00379	CbGeAlD
Quetiapine—CHRM2—forebrain—epilepsy syndrome	0.000119	0.00377	CbGeAlD
Quetiapine—HTR2C—brainstem—epilepsy syndrome	0.000119	0.00377	CbGeAlD
Quetiapine—DRD3—head—epilepsy syndrome	0.000118	0.00374	CbGeAlD
Quetiapine—CHRM4—central nervous system—epilepsy syndrome	0.000116	0.00368	CbGeAlD
Quetiapine—HTR1D—forebrain—epilepsy syndrome	0.000116	0.00367	CbGeAlD
Quetiapine—HTR2C—forebrain—epilepsy syndrome	0.000115	0.00364	CbGeAlD
Quetiapine—HTR6—head—epilepsy syndrome	0.000114	0.0036	CbGeAlD
Quetiapine—DRD3—nervous system—epilepsy syndrome	0.000112	0.00355	CbGeAlD
Quetiapine—DRD5—head—epilepsy syndrome	0.000111	0.00351	CbGeAlD
Quetiapine—HTR1B—telencephalon—epilepsy syndrome	0.00011	0.00349	CbGeAlD
Quetiapine—CHRM2—telencephalon—epilepsy syndrome	0.00011	0.00347	CbGeAlD
Quetiapine—CHRM1—forebrain—epilepsy syndrome	0.000109	0.00343	CbGeAlD
Quetiapine—H1F0—medulla oblongata—epilepsy syndrome	0.000108	0.00343	CbGeAlD
Quetiapine—DRD3—central nervous system—epilepsy syndrome	0.000108	0.00342	CbGeAlD
Quetiapine—HTR6—nervous system—epilepsy syndrome	0.000108	0.00342	CbGeAlD
Quetiapine—HTR1D—telencephalon—epilepsy syndrome	0.000107	0.00338	CbGeAlD
Quetiapine—HTR2C—telencephalon—epilepsy syndrome	0.000106	0.00334	CbGeAlD
Quetiapine—HTR1E—brain—epilepsy syndrome	0.000105	0.00333	CbGeAlD
Quetiapine—DRD5—nervous system—epilepsy syndrome	0.000105	0.00333	CbGeAlD
Quetiapine—HTR2A—hindbrain—epilepsy syndrome	0.000104	0.0033	CbGeAlD
Quetiapine—HTR6—central nervous system—epilepsy syndrome	0.000104	0.00329	CbGeAlD
Quetiapine—DRD5—central nervous system—epilepsy syndrome	0.000101	0.0032	CbGeAlD
Quetiapine—HTR1A—brainstem—epilepsy syndrome	0.0001	0.00317	CbGeAlD
Quetiapine—CHRM1—telencephalon—epilepsy syndrome	9.98e-05	0.00316	CbGeAlD
Quetiapine—CHRM5—head—epilepsy syndrome	9.95e-05	0.00315	CbGeAlD
Quetiapine—H1F0—midbrain—epilepsy syndrome	9.9e-05	0.00313	CbGeAlD
Quetiapine—DRD1—midbrain—epilepsy syndrome	9.77e-05	0.00309	CbGeAlD
Quetiapine—CHRM3—forebrain—epilepsy syndrome	9.72e-05	0.00307	CbGeAlD
Quetiapine—HTR1A—forebrain—epilepsy syndrome	9.68e-05	0.00306	CbGeAlD
Quetiapine—H1F0—spinal cord—epilepsy syndrome	9.66e-05	0.00305	CbGeAlD
Quetiapine—HTR7—brainstem—epilepsy syndrome	9.58e-05	0.00303	CbGeAlD
Quetiapine—CYP2D6—hindbrain—epilepsy syndrome	9.5e-05	0.003	CbGeAlD
Quetiapine—CHRM5—nervous system—epilepsy syndrome	9.43e-05	0.00298	CbGeAlD
Quetiapine—HTR7—forebrain—epilepsy syndrome	9.25e-05	0.00293	CbGeAlD
Quetiapine—ADRA1A—brainstem—epilepsy syndrome	9.24e-05	0.00292	CbGeAlD
Quetiapine—CHRM4—brain—epilepsy syndrome	9.23e-05	0.00292	CbGeAlD
Quetiapine—ADRA1B—head—epilepsy syndrome	9.09e-05	0.00288	CbGeAlD
Quetiapine—CHRM5—central nervous system—epilepsy syndrome	9.08e-05	0.00287	CbGeAlD
Quetiapine—DRD2—brainstem—epilepsy syndrome	9.06e-05	0.00287	CbGeAlD
Quetiapine—CHRM3—telencephalon—epilepsy syndrome	8.94e-05	0.00283	CbGeAlD
Quetiapine—ADRA1A—forebrain—epilepsy syndrome	8.92e-05	0.00282	CbGeAlD
Quetiapine—HTR1A—telencephalon—epilepsy syndrome	8.9e-05	0.00281	CbGeAlD
Quetiapine—ADRA1D—head—epilepsy syndrome	8.89e-05	0.00281	CbGeAlD
Quetiapine—DRD2—forebrain—epilepsy syndrome	8.74e-05	0.00277	CbGeAlD
Quetiapine—ADRA1B—nervous system—epilepsy syndrome	8.62e-05	0.00273	CbGeAlD
Quetiapine—H1F0—head—epilepsy syndrome	8.58e-05	0.00271	CbGeAlD
Quetiapine—DRD3—brain—epilepsy syndrome	8.58e-05	0.00271	CbGeAlD
Quetiapine—HTR7—telencephalon—epilepsy syndrome	8.5e-05	0.00269	CbGeAlD
Quetiapine—DRD1—head—epilepsy syndrome	8.48e-05	0.00268	CbGeAlD
Quetiapine—ADRA1D—nervous system—epilepsy syndrome	8.43e-05	0.00267	CbGeAlD
Quetiapine—HTR2C—medulla oblongata—epilepsy syndrome	8.31e-05	0.00263	CbGeAlD
Quetiapine—ADRA1B—central nervous system—epilepsy syndrome	8.3e-05	0.00263	CbGeAlD
Quetiapine—HTR6—brain—epilepsy syndrome	8.26e-05	0.00261	CbGeAlD
Quetiapine—ADRA1A—telencephalon—epilepsy syndrome	8.2e-05	0.00259	CbGeAlD
Quetiapine—HTR3A—head—epilepsy syndrome	8.19e-05	0.00259	CbGeAlD
Quetiapine—H1F0—nervous system—epilepsy syndrome	8.14e-05	0.00257	CbGeAlD
Quetiapine—ADRA1D—central nervous system—epilepsy syndrome	8.12e-05	0.00257	CbGeAlD
Quetiapine—DRD2—telencephalon—epilepsy syndrome	8.04e-05	0.00254	CbGeAlD
Quetiapine—DRD5—brain—epilepsy syndrome	8.04e-05	0.00254	CbGeAlD
Quetiapine—DRD1—nervous system—epilepsy syndrome	8.04e-05	0.00254	CbGeAlD
Quetiapine—HTR1B—midbrain—epilepsy syndrome	7.92e-05	0.00251	CbGeAlD
Quetiapine—H1F0—central nervous system—epilepsy syndrome	7.83e-05	0.00248	CbGeAlD
Quetiapine—ADRA2C—telencephalon—epilepsy syndrome	7.82e-05	0.00247	CbGeAlD
Quetiapine—HTR3A—nervous system—epilepsy syndrome	7.76e-05	0.00245	CbGeAlD
Quetiapine—DRD1—central nervous system—epilepsy syndrome	7.74e-05	0.00245	CbGeAlD
Quetiapine—HTR1B—spinal cord—epilepsy syndrome	7.73e-05	0.00244	CbGeAlD
Quetiapine—Flupentixol—CHRM1—epilepsy syndrome	7.7e-05	0.0414	CrCbGaD
Quetiapine—HTR1D—midbrain—epilepsy syndrome	7.67e-05	0.00243	CbGeAlD
Quetiapine—H1F0—cerebellum—epilepsy syndrome	7.66e-05	0.00242	CbGeAlD
Quetiapine—HTR2C—midbrain—epilepsy syndrome	7.59e-05	0.0024	CbGeAlD
Quetiapine—HTR3A—central nervous system—epilepsy syndrome	7.47e-05	0.00236	CbGeAlD
Quetiapine—HTR2C—spinal cord—epilepsy syndrome	7.41e-05	0.00234	CbGeAlD
Quetiapine—CHRM5—brain—epilepsy syndrome	7.21e-05	0.00228	CbGeAlD
Quetiapine—HRH1—forebrain—epilepsy syndrome	6.91e-05	0.00218	CbGeAlD
Quetiapine—HTR1B—head—epilepsy syndrome	6.87e-05	0.00217	CbGeAlD
Quetiapine—CHRM2—head—epilepsy syndrome	6.83e-05	0.00216	CbGeAlD
Quetiapine—ADRA2A—forebrain—epilepsy syndrome	6.78e-05	0.00215	CbGeAlD
Quetiapine—HTR7—medulla oblongata—epilepsy syndrome	6.68e-05	0.00211	CbGeAlD
Quetiapine—HTR1D—head—epilepsy syndrome	6.65e-05	0.0021	CbGeAlD
Quetiapine—ADRA1B—brain—epilepsy syndrome	6.59e-05	0.00208	CbGeAlD
Quetiapine—HTR2C—head—epilepsy syndrome	6.58e-05	0.00208	CbGeAlD
Quetiapine—HTR1B—nervous system—epilepsy syndrome	6.51e-05	0.00206	CbGeAlD
Quetiapine—CHRM2—nervous system—epilepsy syndrome	6.48e-05	0.00205	CbGeAlD
Quetiapine—ADRA1D—brain—epilepsy syndrome	6.45e-05	0.00204	CbGeAlD
Quetiapine—HTR1A—midbrain—epilepsy syndrome	6.39e-05	0.00202	CbGeAlD
Quetiapine—HRH1—telencephalon—epilepsy syndrome	6.35e-05	0.00201	CbGeAlD
Quetiapine—HTR1D—nervous system—epilepsy syndrome	6.3e-05	0.00199	CbGeAlD
Quetiapine—HTR1B—central nervous system—epilepsy syndrome	6.27e-05	0.00198	CbGeAlD
Quetiapine—HTR2C—nervous system—epilepsy syndrome	6.24e-05	0.00197	CbGeAlD
Quetiapine—ADRA2A—telencephalon—epilepsy syndrome	6.24e-05	0.00197	CbGeAlD
Quetiapine—HTR1A—spinal cord—epilepsy syndrome	6.24e-05	0.00197	CbGeAlD
Quetiapine—CHRM2—central nervous system—epilepsy syndrome	6.23e-05	0.00197	CbGeAlD
Quetiapine—H1F0—brain—epilepsy syndrome	6.22e-05	0.00197	CbGeAlD
Quetiapine—CHRM1—head—epilepsy syndrome	6.22e-05	0.00197	CbGeAlD
Quetiapine—ADRA2C—medulla oblongata—epilepsy syndrome	6.14e-05	0.00194	CbGeAlD
Quetiapine—DRD1—brain—epilepsy syndrome	6.14e-05	0.00194	CbGeAlD
Quetiapine—HTR7—midbrain—epilepsy syndrome	6.11e-05	0.00193	CbGeAlD
Quetiapine—HTR1D—central nervous system—epilepsy syndrome	6.07e-05	0.00192	CbGeAlD
Quetiapine—Metixene—CHRM3—epilepsy syndrome	6.02e-05	0.0323	CrCbGaD
Quetiapine—HTR2C—central nervous system—epilepsy syndrome	6.01e-05	0.0019	CbGeAlD
Quetiapine—HTR2A—brainstem—epilepsy syndrome	5.98e-05	0.00189	CbGeAlD
Quetiapine—HTR7—spinal cord—epilepsy syndrome	5.96e-05	0.00188	CbGeAlD
Quetiapine—HTR3A—brain—epilepsy syndrome	5.93e-05	0.00188	CbGeAlD
Quetiapine—CHRM1—nervous system—epilepsy syndrome	5.89e-05	0.00186	CbGeAlD
Quetiapine—DRD2—midbrain—epilepsy syndrome	5.77e-05	0.00183	CbGeAlD
Quetiapine—HTR2A—forebrain—epilepsy syndrome	5.77e-05	0.00182	CbGeAlD
Quetiapine—CHRM1—central nervous system—epilepsy syndrome	5.68e-05	0.0018	CbGeAlD
Quetiapine—Metixene—CHRM1—epilepsy syndrome	5.62e-05	0.0302	CrCbGaD
Quetiapine—ADRA2C—midbrain—epilepsy syndrome	5.61e-05	0.00178	CbGeAlD
Quetiapine—CHRM3—head—epilepsy syndrome	5.56e-05	0.00176	CbGeAlD
Quetiapine—HTR1A—head—epilepsy syndrome	5.54e-05	0.00175	CbGeAlD
Quetiapine—ADRA2C—spinal cord—epilepsy syndrome	5.48e-05	0.00173	CbGeAlD
Quetiapine—CYP2D6—brainstem—epilepsy syndrome	5.44e-05	0.00172	CbGeAlD
Quetiapine—HTR2A—telencephalon—epilepsy syndrome	5.3e-05	0.00168	CbGeAlD
Quetiapine—HTR7—head—epilepsy syndrome	5.3e-05	0.00168	CbGeAlD
Quetiapine—CHRM3—nervous system—epilepsy syndrome	5.28e-05	0.00167	CbGeAlD
Quetiapine—CYP2D6—forebrain—epilepsy syndrome	5.25e-05	0.00166	CbGeAlD
Quetiapine—HTR1A—nervous system—epilepsy syndrome	5.25e-05	0.00166	CbGeAlD
Quetiapine—ADRA1A—head—epilepsy syndrome	5.11e-05	0.00162	CbGeAlD
Quetiapine—CHRM3—central nervous system—epilepsy syndrome	5.08e-05	0.00161	CbGeAlD
Quetiapine—HTR1A—central nervous system—epilepsy syndrome	5.06e-05	0.0016	CbGeAlD
Quetiapine—HTR7—nervous system—epilepsy syndrome	5.02e-05	0.00159	CbGeAlD
Quetiapine—DRD2—head—epilepsy syndrome	5.01e-05	0.00158	CbGeAlD
Quetiapine—HTR1B—brain—epilepsy syndrome	4.98e-05	0.00157	CbGeAlD
Quetiapine—CHRM2—brain—epilepsy syndrome	4.95e-05	0.00157	CbGeAlD
Quetiapine—HTR1A—cerebellum—epilepsy syndrome	4.94e-05	0.00156	CbGeAlD
Quetiapine—ADRA2A—medulla oblongata—epilepsy syndrome	4.9e-05	0.00155	CbGeAlD
Quetiapine—ADRA2C—head—epilepsy syndrome	4.87e-05	0.00154	CbGeAlD
Quetiapine—ADRA1A—nervous system—epilepsy syndrome	4.84e-05	0.00153	CbGeAlD
Quetiapine—HTR7—central nervous system—epilepsy syndrome	4.83e-05	0.00153	CbGeAlD
Quetiapine—CYP2D6—telencephalon—epilepsy syndrome	4.83e-05	0.00153	CbGeAlD
Quetiapine—HTR1D—brain—epilepsy syndrome	4.82e-05	0.00152	CbGeAlD
Quetiapine—HTR2C—brain—epilepsy syndrome	4.77e-05	0.00151	CbGeAlD
Quetiapine—DRD2—nervous system—epilepsy syndrome	4.75e-05	0.0015	CbGeAlD
Quetiapine—HTR7—cerebellum—epilepsy syndrome	4.72e-05	0.00149	CbGeAlD
Quetiapine—ADRA1A—central nervous system—epilepsy syndrome	4.66e-05	0.00147	CbGeAlD
Quetiapine—ADRA2C—nervous system—epilepsy syndrome	4.61e-05	0.00146	CbGeAlD
Quetiapine—Metixene—CHRM2—epilepsy syndrome	4.59e-05	0.0246	CrCbGaD
Quetiapine—DRD2—central nervous system—epilepsy syndrome	4.57e-05	0.00145	CbGeAlD
Quetiapine—ADRA1A—cerebellum—epilepsy syndrome	4.56e-05	0.00144	CbGeAlD
Quetiapine—CHRM1—brain—epilepsy syndrome	4.51e-05	0.00143	CbGeAlD
Quetiapine—ADRA2A—midbrain—epilepsy syndrome	4.48e-05	0.00142	CbGeAlD
Quetiapine—DRD2—cerebellum—epilepsy syndrome	4.47e-05	0.00141	CbGeAlD
Quetiapine—ADRA2C—central nervous system—epilepsy syndrome	4.44e-05	0.00141	CbGeAlD
Quetiapine—Olanzapine—CHRM3—epilepsy syndrome	4.42e-05	0.0237	CrCbGaD
Quetiapine—ADRA2A—spinal cord—epilepsy syndrome	4.37e-05	0.00138	CbGeAlD
Quetiapine—ADRA2C—cerebellum—epilepsy syndrome	4.34e-05	0.00137	CbGeAlD
Quetiapine—Mequitazine—CHRM2—epilepsy syndrome	4.28e-05	0.023	CrCbGaD
Quetiapine—Propericiazine—ADRA2A—epilepsy syndrome	4.21e-05	0.0226	CrCbGaD
Quetiapine—HTR2A—medulla oblongata—epilepsy syndrome	4.17e-05	0.00132	CbGeAlD
Quetiapine—Olanzapine—CHRM1—epilepsy syndrome	4.12e-05	0.0221	CrCbGaD
Quetiapine—CHRM3—brain—epilepsy syndrome	4.03e-05	0.00128	CbGeAlD
Quetiapine—HTR1A—brain—epilepsy syndrome	4.02e-05	0.00127	CbGeAlD
Quetiapine—HRH1—head—epilepsy syndrome	3.95e-05	0.00125	CbGeAlD
Quetiapine—ADRA2A—head—epilepsy syndrome	3.88e-05	0.00123	CbGeAlD
Quetiapine—Clozapine—HRH3—epilepsy syndrome	3.85e-05	0.0207	CrCbGaD
Quetiapine—HTR7—brain—epilepsy syndrome	3.84e-05	0.00121	CbGeAlD
Quetiapine—HTR2A—midbrain—epilepsy syndrome	3.81e-05	0.0012	CbGeAlD
Quetiapine—ABCB1—forebrain—epilepsy syndrome	3.78e-05	0.0012	CbGeAlD
Quetiapine—HRH1—nervous system—epilepsy syndrome	3.75e-05	0.00119	CbGeAlD
Quetiapine—HTR2A—spinal cord—epilepsy syndrome	3.72e-05	0.00118	CbGeAlD
Quetiapine—ADRA1A—brain—epilepsy syndrome	3.7e-05	0.00117	CbGeAlD
Quetiapine—ADRA2A—nervous system—epilepsy syndrome	3.68e-05	0.00116	CbGeAlD
Quetiapine—DRD2—brain—epilepsy syndrome	3.63e-05	0.00115	CbGeAlD
Quetiapine—HRH1—central nervous system—epilepsy syndrome	3.61e-05	0.00114	CbGeAlD
Quetiapine—ADRA2A—central nervous system—epilepsy syndrome	3.55e-05	0.00112	CbGeAlD
Quetiapine—ADRA2C—brain—epilepsy syndrome	3.53e-05	0.00112	CbGeAlD
Quetiapine—Amoxapine—GABRA1—epilepsy syndrome	3.52e-05	0.0189	CrCbGaD
Quetiapine—ABCB1—telencephalon—epilepsy syndrome	3.48e-05	0.0011	CbGeAlD
Quetiapine—ADRA2A—cerebellum—epilepsy syndrome	3.47e-05	0.0011	CbGeAlD
Quetiapine—Olanzapine—CHRM2—epilepsy syndrome	3.37e-05	0.0181	CrCbGaD
Quetiapine—Olanzapine—HTR7—epilepsy syndrome	3.35e-05	0.018	CrCbGaD
Quetiapine—HTR2A—head—epilepsy syndrome	3.3e-05	0.00104	CbGeAlD
Quetiapine—Amoxapine—CHRM1—epilepsy syndrome	3.28e-05	0.0176	CrCbGaD
Quetiapine—Flupentixol—HTR2A—epilepsy syndrome	3.15e-05	0.0169	CrCbGaD
Quetiapine—HTR2A—nervous system—epilepsy syndrome	3.13e-05	0.00099	CbGeAlD
Quetiapine—Zuclopenthixol—ADRA2A—epilepsy syndrome	3.02e-05	0.0162	CrCbGaD
Quetiapine—HTR2A—central nervous system—epilepsy syndrome	3.01e-05	0.000954	CbGeAlD
Quetiapine—CYP2D6—head—epilepsy syndrome	3.01e-05	0.000952	CbGeAlD
Quetiapine—Hydroxyzine—CYP2D6—epilepsy syndrome	3.01e-05	0.0161	CrCbGaD
Quetiapine—Nefazodone—ADRA2A—epilepsy syndrome	3e-05	0.0161	CrCbGaD
Quetiapine—HTR2A—cerebellum—epilepsy syndrome	2.95e-05	0.000932	CbGeAlD
Quetiapine—Prochlorperazine—CHRM2—epilepsy syndrome	2.91e-05	0.0156	CrCbGaD
Quetiapine—CYP3A4—nervous system—epilepsy syndrome	2.9e-05	0.000917	CbGeAlD
Quetiapine—Olanzapine—ADRA2A—epilepsy syndrome	2.87e-05	0.0154	CrCbGaD
Quetiapine—HRH1—brain—epilepsy syndrome	2.87e-05	0.000906	CbGeAlD
Quetiapine—CYP2D6—nervous system—epilepsy syndrome	2.85e-05	0.000902	CbGeAlD
Quetiapine—ADRA2A—brain—epilepsy syndrome	2.81e-05	0.00089	CbGeAlD
Quetiapine—CYP3A4—central nervous system—epilepsy syndrome	2.79e-05	0.000883	CbGeAlD
Quetiapine—Trazodone—ADRA2A—epilepsy syndrome	2.78e-05	0.0149	CrCbGaD
Quetiapine—Loxapine—CHRM3—epilepsy syndrome	2.75e-05	0.0148	CrCbGaD
Quetiapine—CYP2D6—central nervous system—epilepsy syndrome	2.75e-05	0.000869	CbGeAlD
Quetiapine—ABCB1—medulla oblongata—epilepsy syndrome	2.73e-05	0.000864	CbGeAlD
Quetiapine—CYP2D6—cerebellum—epilepsy syndrome	2.68e-05	0.000849	CbGeAlD
Quetiapine—Amoxapine—HTR7—epilepsy syndrome	2.67e-05	0.0143	CrCbGaD
Quetiapine—Thiothixene—ADRA2A—epilepsy syndrome	2.6e-05	0.014	CrCbGaD
Quetiapine—Loxapine—CHRM1—epilepsy syndrome	2.56e-05	0.0138	CrCbGaD
Quetiapine—ABCB1—midbrain—epilepsy syndrome	2.5e-05	0.000789	CbGeAlD
Quetiapine—Promazine—CHRM3—epilepsy syndrome	2.47e-05	0.0132	CrCbGaD
Quetiapine—ABCB1—spinal cord—epilepsy syndrome	2.44e-05	0.00077	CbGeAlD
Quetiapine—HTR2A—brain—epilepsy syndrome	2.39e-05	0.000757	CbGeAlD
Quetiapine—Clozapine—CHRM3—epilepsy syndrome	2.31e-05	0.0124	CrCbGaD
Quetiapine—Promazine—CHRM1—epilepsy syndrome	2.3e-05	0.0123	CrCbGaD
Quetiapine—Nefazodone—SLC6A4—epilepsy syndrome	2.29e-05	0.0123	CrCbGaD
Quetiapine—Amoxapine—ADRA2A—epilepsy syndrome	2.29e-05	0.0123	CrCbGaD
Quetiapine—Fluphenazine—ADRA2A—epilepsy syndrome	2.25e-05	0.0121	CrCbGaD
Quetiapine—CYP2D6—brain—epilepsy syndrome	2.18e-05	0.00069	CbGeAlD
Quetiapine—ABCB1—head—epilepsy syndrome	2.16e-05	0.000685	CbGeAlD
Quetiapine—Clozapine—CHRM1—epilepsy syndrome	2.15e-05	0.0116	CrCbGaD
Quetiapine—Trazodone—SLC6A4—epilepsy syndrome	2.12e-05	0.0114	CrCbGaD
Quetiapine—Trifluoperazine—CHRM2—epilepsy syndrome	2.11e-05	0.0113	CrCbGaD
Quetiapine—Loxapine—CHRM2—epilepsy syndrome	2.09e-05	0.0112	CrCbGaD
Quetiapine—Loxapine—HTR7—epilepsy syndrome	2.08e-05	0.0112	CrCbGaD
Quetiapine—Olanzapine—CYP2C19—epilepsy syndrome	2.08e-05	0.0112	CrCbGaD
Quetiapine—Perphenazine—HTR7—epilepsy syndrome	2.07e-05	0.0111	CrCbGaD
Quetiapine—Flupentixol—ABCB1—epilepsy syndrome	2.06e-05	0.011	CrCbGaD
Quetiapine—ABCB1—nervous system—epilepsy syndrome	2.05e-05	0.000649	CbGeAlD
Quetiapine—ABCB1—central nervous system—epilepsy syndrome	1.98e-05	0.000625	CbGeAlD
Quetiapine—Mequitazine—CYP2D6—epilepsy syndrome	1.96e-05	0.0105	CrCbGaD
Quetiapine—ABCB1—cerebellum—epilepsy syndrome	1.93e-05	0.000611	CbGeAlD
Quetiapine—Pipotiazine—CYP2C19—epilepsy syndrome	1.88e-05	0.0101	CrCbGaD
Quetiapine—Promazine—CHRM2—epilepsy syndrome	1.88e-05	0.0101	CrCbGaD
Quetiapine—Loxapine—ADRA2A—epilepsy syndrome	1.79e-05	0.00959	CrCbGaD
Quetiapine—Perphenazine—ADRA2A—epilepsy syndrome	1.78e-05	0.00955	CrCbGaD
Quetiapine—Zuclopenthixol—HTR2A—epilepsy syndrome	1.77e-05	0.0095	CrCbGaD
Quetiapine—Nefazodone—HTR2A—epilepsy syndrome	1.76e-05	0.00944	CrCbGaD
Quetiapine—Clozapine—CHRM2—epilepsy syndrome	1.76e-05	0.00943	CrCbGaD
Quetiapine—Clozapine—HTR7—epilepsy syndrome	1.75e-05	0.00939	CrCbGaD
Quetiapine—Amoxapine—SLC6A4—epilepsy syndrome	1.74e-05	0.00937	CrCbGaD
Quetiapine—Olanzapine—HTR2A—epilepsy syndrome	1.68e-05	0.00904	CrCbGaD
Quetiapine—Trazodone—HTR2A—epilepsy syndrome	1.63e-05	0.00874	CrCbGaD
Quetiapine—Zuclopenthixol—CYP2D6—epilepsy syndrome	1.62e-05	0.00869	CrCbGaD
Quetiapine—Nefazodone—CYP2D6—epilepsy syndrome	1.61e-05	0.00864	CrCbGaD
Quetiapine—Promazine—ADRA2A—epilepsy syndrome	1.6e-05	0.00861	CrCbGaD
Quetiapine—ABCB1—brain—epilepsy syndrome	1.57e-05	0.000496	CbGeAlD
Quetiapine—Thioproperazine—HTR2A—epilepsy syndrome	1.55e-05	0.00832	CrCbGaD
Quetiapine—Olanzapine—CYP2D6—epilepsy syndrome	1.54e-05	0.00827	CrCbGaD
Quetiapine—Pipotiazine—HTR2A—epilepsy syndrome	1.52e-05	0.00819	CrCbGaD
Quetiapine—Thiothixene—HTR2A—epilepsy syndrome	1.52e-05	0.00819	CrCbGaD
Quetiapine—Clozapine—ADRA2A—epilepsy syndrome	1.5e-05	0.00805	CrCbGaD
Quetiapine—Trazodone—CYP2D6—epilepsy syndrome	1.49e-05	0.00799	CrCbGaD
Quetiapine—Pipotiazine—CYP2D6—epilepsy syndrome	1.39e-05	0.00749	CrCbGaD
Quetiapine—Thiothixene—CYP2D6—epilepsy syndrome	1.39e-05	0.00749	CrCbGaD
Quetiapine—Loxapine—SLC6A4—epilepsy syndrome	1.36e-05	0.00732	CrCbGaD
Quetiapine—Amoxapine—HTR2A—epilepsy syndrome	1.34e-05	0.0072	CrCbGaD
Quetiapine—Prochlorperazine—CYP2D6—epilepsy syndrome	1.33e-05	0.00716	CrCbGaD
Quetiapine—Fluphenazine—HTR2A—epilepsy syndrome	1.32e-05	0.00708	CrCbGaD
Quetiapine—Perphenazine—CYP2C19—epilepsy syndrome	1.29e-05	0.0069	CrCbGaD
Quetiapine—Amoxapine—CYP2D6—epilepsy syndrome	1.23e-05	0.00658	CrCbGaD
Quetiapine—Fluphenazine—CYP2D6—epilepsy syndrome	1.21e-05	0.00647	CrCbGaD
Quetiapine—Promazine—CYP2C19—epilepsy syndrome	1.16e-05	0.00622	CrCbGaD
Quetiapine—Olanzapine—ALB—epilepsy syndrome	1.15e-05	0.00619	CrCbGaD
Quetiapine—Nefazodone—ABCB1—epilepsy syndrome	1.15e-05	0.00617	CrCbGaD
Quetiapine—Olanzapine—ABCB1—epilepsy syndrome	1.1e-05	0.00591	CrCbGaD
Quetiapine—Clozapine—CYP2C19—epilepsy syndrome	1.08e-05	0.00582	CrCbGaD
Quetiapine—Trazodone—ABCB1—epilepsy syndrome	1.06e-05	0.00571	CrCbGaD
Quetiapine—Thioproperazine—ALB—epilepsy syndrome	1.06e-05	0.0057	CrCbGaD
Quetiapine—Trifluoperazine—HTR2A—epilepsy syndrome	1.05e-05	0.00566	CrCbGaD
Quetiapine—Loxapine—HTR2A—epilepsy syndrome	1.05e-05	0.00562	CrCbGaD
Quetiapine—Pipotiazine—ALB—epilepsy syndrome	1.04e-05	0.0056	CrCbGaD
Quetiapine—Thiothixene—ALB—epilepsy syndrome	1.04e-05	0.0056	CrCbGaD
Quetiapine—Perphenazine—HTR2A—epilepsy syndrome	1.04e-05	0.0056	CrCbGaD
Quetiapine—Perphenazine—CYP2D6—epilepsy syndrome	9.53e-06	0.00512	CrCbGaD
Quetiapine—Promazine—HTR2A—epilepsy syndrome	9.39e-06	0.00504	CrCbGaD
Quetiapine—Clozapine—HTR2A—epilepsy syndrome	8.79e-06	0.00472	CrCbGaD
Quetiapine—Myalgia—Pregabalin—epilepsy syndrome	8.69e-06	8.94e-05	CcSEcCtD
Quetiapine—Chest pain—Pregabalin—epilepsy syndrome	8.69e-06	8.94e-05	CcSEcCtD
Quetiapine—Ill-defined disorder—Gabapentin—epilepsy syndrome	8.68e-06	8.94e-05	CcSEcCtD
Quetiapine—Dizziness—Zonisamide—epilepsy syndrome	8.68e-06	8.93e-05	CcSEcCtD
Quetiapine—Headache—Diazepam—epilepsy syndrome	8.68e-06	8.93e-05	CcSEcCtD
Quetiapine—Anxiety—Pregabalin—epilepsy syndrome	8.66e-06	8.91e-05	CcSEcCtD
Quetiapine—Diarrhoea—Clonazepam—epilepsy syndrome	8.65e-06	8.91e-05	CcSEcCtD
Quetiapine—Anaemia—Gabapentin—epilepsy syndrome	8.65e-06	8.9e-05	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	8.63e-06	8.88e-05	CcSEcCtD
Quetiapine—Hypotension—Valproic Acid—epilepsy syndrome	8.61e-06	8.86e-05	CcSEcCtD
Quetiapine—Fluphenazine—ABCB1—epilepsy syndrome	8.61e-06	0.00462	CrCbGaD
Quetiapine—Asthenia—Carbamazepine—epilepsy syndrome	8.6e-06	8.86e-05	CcSEcCtD
Quetiapine—Agitation—Gabapentin—epilepsy syndrome	8.6e-06	8.85e-05	CcSEcCtD
Quetiapine—Diarrhoea—Phenytoin—epilepsy syndrome	8.6e-06	8.85e-05	CcSEcCtD
Quetiapine—Discomfort—Pregabalin—epilepsy syndrome	8.58e-06	8.83e-05	CcSEcCtD
Quetiapine—Nausea—Fosphenytoin—epilepsy syndrome	8.57e-06	8.83e-05	CcSEcCtD
Quetiapine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	8.55e-06	8.8e-05	CcSEcCtD
Quetiapine—Erythema multiforme—Topiramate—epilepsy syndrome	8.55e-06	8.8e-05	CcSEcCtD
Quetiapine—Angioedema—Gabapentin—epilepsy syndrome	8.55e-06	8.8e-05	CcSEcCtD
Quetiapine—Hypersensitivity—Lamotrigine—epilepsy syndrome	8.54e-06	8.79e-05	CcSEcCtD
Quetiapine—Vomiting—Felbamate—epilepsy syndrome	8.52e-06	8.78e-05	CcSEcCtD
Quetiapine—Dry mouth—Pregabalin—epilepsy syndrome	8.49e-06	8.74e-05	CcSEcCtD
Quetiapine—Pruritus—Carbamazepine—epilepsy syndrome	8.48e-06	8.73e-05	CcSEcCtD
Quetiapine—Rash—Felbamate—epilepsy syndrome	8.45e-06	8.7e-05	CcSEcCtD
Quetiapine—Eye disorder—Topiramate—epilepsy syndrome	8.45e-06	8.7e-05	CcSEcCtD
Quetiapine—Dermatitis—Felbamate—epilepsy syndrome	8.45e-06	8.69e-05	CcSEcCtD
Quetiapine—Malaise—Gabapentin—epilepsy syndrome	8.44e-06	8.68e-05	CcSEcCtD
Quetiapine—Tinnitus—Topiramate—epilepsy syndrome	8.43e-06	8.68e-05	CcSEcCtD
Quetiapine—Vertigo—Gabapentin—epilepsy syndrome	8.41e-06	8.65e-05	CcSEcCtD
Quetiapine—Headache—Felbamate—epilepsy syndrome	8.4e-06	8.65e-05	CcSEcCtD
Quetiapine—Confusional state—Pregabalin—epilepsy syndrome	8.4e-06	8.64e-05	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	8.39e-06	8.64e-05	CcSEcCtD
Quetiapine—Cardiac disorder—Topiramate—epilepsy syndrome	8.39e-06	8.64e-05	CcSEcCtD
Quetiapine—Syncope—Gabapentin—epilepsy syndrome	8.39e-06	8.64e-05	CcSEcCtD
Quetiapine—Leukopenia—Gabapentin—epilepsy syndrome	8.37e-06	8.62e-05	CcSEcCtD
Quetiapine—Dizziness—Clonazepam—epilepsy syndrome	8.36e-06	8.61e-05	CcSEcCtD
Quetiapine—Nausea—Vigabatrin—epilepsy syndrome	8.36e-06	8.6e-05	CcSEcCtD
Quetiapine—Vomiting—Zonisamide—epilepsy syndrome	8.34e-06	8.59e-05	CcSEcCtD
Quetiapine—Insomnia—Valproic Acid—epilepsy syndrome	8.33e-06	8.58e-05	CcSEcCtD
Quetiapine—Anaphylactic shock—Pregabalin—epilepsy syndrome	8.33e-06	8.57e-05	CcSEcCtD
Quetiapine—Asthenia—Lamotrigine—epilepsy syndrome	8.32e-06	8.56e-05	CcSEcCtD
Quetiapine—Dizziness—Phenytoin—epilepsy syndrome	8.31e-06	8.55e-05	CcSEcCtD
Quetiapine—Rash—Zonisamide—epilepsy syndrome	8.28e-06	8.52e-05	CcSEcCtD
Quetiapine—Infection—Pregabalin—epilepsy syndrome	8.27e-06	8.52e-05	CcSEcCtD
Quetiapine—Paraesthesia—Valproic Acid—epilepsy syndrome	8.27e-06	8.51e-05	CcSEcCtD
Quetiapine—Palpitations—Gabapentin—epilepsy syndrome	8.27e-06	8.51e-05	CcSEcCtD
Quetiapine—Dermatitis—Zonisamide—epilepsy syndrome	8.27e-06	8.51e-05	CcSEcCtD
Quetiapine—Dizziness—Oxcarbazepine—epilepsy syndrome	8.26e-06	8.51e-05	CcSEcCtD
Quetiapine—Nausea—Diazepam—epilepsy syndrome	8.23e-06	8.47e-05	CcSEcCtD
Quetiapine—Loss of consciousness—Gabapentin—epilepsy syndrome	8.22e-06	8.46e-05	CcSEcCtD
Quetiapine—Headache—Zonisamide—epilepsy syndrome	8.22e-06	8.46e-05	CcSEcCtD
Quetiapine—Dyspnoea—Valproic Acid—epilepsy syndrome	8.21e-06	8.45e-05	CcSEcCtD
Quetiapine—Diarrhoea—Carbamazepine—epilepsy syndrome	8.21e-06	8.45e-05	CcSEcCtD
Quetiapine—Angiopathy—Topiramate—epilepsy syndrome	8.2e-06	8.44e-05	CcSEcCtD
Quetiapine—Pruritus—Lamotrigine—epilepsy syndrome	8.2e-06	8.44e-05	CcSEcCtD
Quetiapine—Shock—Pregabalin—epilepsy syndrome	8.19e-06	8.43e-05	CcSEcCtD
Quetiapine—Somnolence—Valproic Acid—epilepsy syndrome	8.19e-06	8.43e-05	CcSEcCtD
Quetiapine—Immune system disorder—Topiramate—epilepsy syndrome	8.17e-06	8.41e-05	CcSEcCtD
Quetiapine—Nervous system disorder—Pregabalin—epilepsy syndrome	8.17e-06	8.41e-05	CcSEcCtD
Quetiapine—Cough—Gabapentin—epilepsy syndrome	8.16e-06	8.4e-05	CcSEcCtD
Quetiapine—Thrombocytopenia—Pregabalin—epilepsy syndrome	8.15e-06	8.39e-05	CcSEcCtD
Quetiapine—Mediastinal disorder—Topiramate—epilepsy syndrome	8.15e-06	8.39e-05	CcSEcCtD
Quetiapine—Tachycardia—Pregabalin—epilepsy syndrome	8.13e-06	8.37e-05	CcSEcCtD
Quetiapine—Chills—Topiramate—epilepsy syndrome	8.11e-06	8.35e-05	CcSEcCtD
Quetiapine—Dyspepsia—Valproic Acid—epilepsy syndrome	8.11e-06	8.35e-05	CcSEcCtD
Quetiapine—Convulsion—Gabapentin—epilepsy syndrome	8.11e-06	8.34e-05	CcSEcCtD
Quetiapine—Skin disorder—Pregabalin—epilepsy syndrome	8.09e-06	8.33e-05	CcSEcCtD
Quetiapine—Hypertension—Gabapentin—epilepsy syndrome	8.08e-06	8.31e-05	CcSEcCtD
Quetiapine—Hyperhidrosis—Pregabalin—epilepsy syndrome	8.05e-06	8.29e-05	CcSEcCtD
Quetiapine—Vomiting—Clonazepam—epilepsy syndrome	8.04e-06	8.28e-05	CcSEcCtD
Quetiapine—Clozapine—CYP2D6—epilepsy syndrome	8.04e-06	0.00432	CrCbGaD
Quetiapine—Decreased appetite—Valproic Acid—epilepsy syndrome	8.01e-06	8.24e-05	CcSEcCtD
Quetiapine—Vomiting—Phenytoin—epilepsy syndrome	7.99e-06	8.22e-05	CcSEcCtD
Quetiapine—Rash—Clonazepam—epilepsy syndrome	7.98e-06	8.21e-05	CcSEcCtD
Quetiapine—Dermatitis—Clonazepam—epilepsy syndrome	7.97e-06	8.2e-05	CcSEcCtD
Quetiapine—Myalgia—Gabapentin—epilepsy syndrome	7.96e-06	8.2e-05	CcSEcCtD
Quetiapine—Chest pain—Gabapentin—epilepsy syndrome	7.96e-06	8.2e-05	CcSEcCtD
Quetiapine—Arthralgia—Gabapentin—epilepsy syndrome	7.96e-06	8.2e-05	CcSEcCtD
Quetiapine—Nausea—Felbamate—epilepsy syndrome	7.96e-06	8.2e-05	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	7.95e-06	8.19e-05	CcSEcCtD
Quetiapine—Vomiting—Oxcarbazepine—epilepsy syndrome	7.95e-06	8.18e-05	CcSEcCtD
Quetiapine—Fatigue—Valproic Acid—epilepsy syndrome	7.94e-06	8.17e-05	CcSEcCtD
Quetiapine—Anxiety—Gabapentin—epilepsy syndrome	7.94e-06	8.17e-05	CcSEcCtD
Quetiapine—Anorexia—Pregabalin—epilepsy syndrome	7.94e-06	8.17e-05	CcSEcCtD
Quetiapine—Dizziness—Carbamazepine—epilepsy syndrome	7.93e-06	8.16e-05	CcSEcCtD
Quetiapine—Diarrhoea—Lamotrigine—epilepsy syndrome	7.93e-06	8.16e-05	CcSEcCtD
Quetiapine—Headache—Clonazepam—epilepsy syndrome	7.92e-06	8.16e-05	CcSEcCtD
Quetiapine—Rash—Phenytoin—epilepsy syndrome	7.92e-06	8.15e-05	CcSEcCtD
Quetiapine—Mental disorder—Topiramate—epilepsy syndrome	7.92e-06	8.15e-05	CcSEcCtD
Quetiapine—Dermatitis—Phenytoin—epilepsy syndrome	7.91e-06	8.15e-05	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	7.91e-06	8.14e-05	CcSEcCtD
Quetiapine—Rash—Oxcarbazepine—epilepsy syndrome	7.88e-06	8.11e-05	CcSEcCtD
Quetiapine—Pain—Valproic Acid—epilepsy syndrome	7.88e-06	8.11e-05	CcSEcCtD
Quetiapine—Constipation—Valproic Acid—epilepsy syndrome	7.88e-06	8.11e-05	CcSEcCtD
Quetiapine—Dermatitis—Oxcarbazepine—epilepsy syndrome	7.87e-06	8.1e-05	CcSEcCtD
Quetiapine—Headache—Phenytoin—epilepsy syndrome	7.87e-06	8.1e-05	CcSEcCtD
Quetiapine—Malnutrition—Topiramate—epilepsy syndrome	7.87e-06	8.1e-05	CcSEcCtD
Quetiapine—Discomfort—Gabapentin—epilepsy syndrome	7.87e-06	8.1e-05	CcSEcCtD
Quetiapine—Headache—Oxcarbazepine—epilepsy syndrome	7.83e-06	8.06e-05	CcSEcCtD
Quetiapine—Nausea—Zonisamide—epilepsy syndrome	7.8e-06	8.02e-05	CcSEcCtD
Quetiapine—Dry mouth—Gabapentin—epilepsy syndrome	7.79e-06	8.02e-05	CcSEcCtD
Quetiapine—Hypotension—Pregabalin—epilepsy syndrome	7.78e-06	8.01e-05	CcSEcCtD
Quetiapine—Flatulence—Topiramate—epilepsy syndrome	7.76e-06	7.98e-05	CcSEcCtD
Quetiapine—Tension—Topiramate—epilepsy syndrome	7.72e-06	7.95e-05	CcSEcCtD
Quetiapine—Dysgeusia—Topiramate—epilepsy syndrome	7.71e-06	7.93e-05	CcSEcCtD
Quetiapine—Confusional state—Gabapentin—epilepsy syndrome	7.7e-06	7.92e-05	CcSEcCtD
Quetiapine—Dizziness—Lamotrigine—epilepsy syndrome	7.66e-06	7.89e-05	CcSEcCtD
Quetiapine—Nervousness—Topiramate—epilepsy syndrome	7.64e-06	7.87e-05	CcSEcCtD
Quetiapine—Anaphylactic shock—Gabapentin—epilepsy syndrome	7.64e-06	7.86e-05	CcSEcCtD
Quetiapine—Vomiting—Carbamazepine—epilepsy syndrome	7.63e-06	7.85e-05	CcSEcCtD
Quetiapine—Back pain—Topiramate—epilepsy syndrome	7.61e-06	7.84e-05	CcSEcCtD
Quetiapine—Feeling abnormal—Valproic Acid—epilepsy syndrome	7.59e-06	7.81e-05	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	7.59e-06	7.81e-05	CcSEcCtD
Quetiapine—Infection—Gabapentin—epilepsy syndrome	7.59e-06	7.81e-05	CcSEcCtD
Quetiapine—Muscle spasms—Topiramate—epilepsy syndrome	7.57e-06	7.79e-05	CcSEcCtD
Quetiapine—Rash—Carbamazepine—epilepsy syndrome	7.56e-06	7.78e-05	CcSEcCtD
Quetiapine—Dermatitis—Carbamazepine—epilepsy syndrome	7.55e-06	7.78e-05	CcSEcCtD
Quetiapine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	7.53e-06	7.75e-05	CcSEcCtD
Quetiapine—Insomnia—Pregabalin—epilepsy syndrome	7.53e-06	7.75e-05	CcSEcCtD
Quetiapine—Nausea—Clonazepam—epilepsy syndrome	7.51e-06	7.73e-05	CcSEcCtD
Quetiapine—Headache—Carbamazepine—epilepsy syndrome	7.51e-06	7.73e-05	CcSEcCtD
Quetiapine—Shock—Gabapentin—epilepsy syndrome	7.51e-06	7.73e-05	CcSEcCtD
Quetiapine—Nervous system disorder—Gabapentin—epilepsy syndrome	7.49e-06	7.71e-05	CcSEcCtD
Quetiapine—Paraesthesia—Pregabalin—epilepsy syndrome	7.48e-06	7.7e-05	CcSEcCtD
Quetiapine—Thrombocytopenia—Gabapentin—epilepsy syndrome	7.48e-06	7.7e-05	CcSEcCtD
Quetiapine—Nausea—Phenytoin—epilepsy syndrome	7.46e-06	7.68e-05	CcSEcCtD
Quetiapine—Tachycardia—Gabapentin—epilepsy syndrome	7.45e-06	7.67e-05	CcSEcCtD
Quetiapine—Dyspnoea—Pregabalin—epilepsy syndrome	7.42e-06	7.64e-05	CcSEcCtD
Quetiapine—Nausea—Oxcarbazepine—epilepsy syndrome	7.42e-06	7.64e-05	CcSEcCtD
Quetiapine—Vision blurred—Topiramate—epilepsy syndrome	7.42e-06	7.64e-05	CcSEcCtD
Quetiapine—Skin disorder—Gabapentin—epilepsy syndrome	7.42e-06	7.63e-05	CcSEcCtD
Quetiapine—Somnolence—Pregabalin—epilepsy syndrome	7.4e-06	7.62e-05	CcSEcCtD
Quetiapine—Hyperhidrosis—Gabapentin—epilepsy syndrome	7.38e-06	7.6e-05	CcSEcCtD
Quetiapine—Tremor—Topiramate—epilepsy syndrome	7.37e-06	7.59e-05	CcSEcCtD
Quetiapine—Vomiting—Lamotrigine—epilepsy syndrome	7.37e-06	7.59e-05	CcSEcCtD
Quetiapine—Rash—Lamotrigine—epilepsy syndrome	7.31e-06	7.52e-05	CcSEcCtD
Quetiapine—Ill-defined disorder—Topiramate—epilepsy syndrome	7.3e-06	7.52e-05	CcSEcCtD
Quetiapine—Dermatitis—Lamotrigine—epilepsy syndrome	7.3e-06	7.52e-05	CcSEcCtD
Quetiapine—Abdominal pain—Valproic Acid—epilepsy syndrome	7.28e-06	7.49e-05	CcSEcCtD
Quetiapine—Body temperature increased—Valproic Acid—epilepsy syndrome	7.28e-06	7.49e-05	CcSEcCtD
Quetiapine—Anorexia—Gabapentin—epilepsy syndrome	7.28e-06	7.49e-05	CcSEcCtD
Quetiapine—Anaemia—Topiramate—epilepsy syndrome	7.27e-06	7.49e-05	CcSEcCtD
Quetiapine—Headache—Lamotrigine—epilepsy syndrome	7.26e-06	7.47e-05	CcSEcCtD
Quetiapine—Decreased appetite—Pregabalin—epilepsy syndrome	7.24e-06	7.45e-05	CcSEcCtD
Quetiapine—Agitation—Topiramate—epilepsy syndrome	7.23e-06	7.45e-05	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	7.19e-06	7.4e-05	CcSEcCtD
Quetiapine—Fatigue—Pregabalin—epilepsy syndrome	7.18e-06	7.39e-05	CcSEcCtD
Quetiapine—Hypotension—Gabapentin—epilepsy syndrome	7.13e-06	7.34e-05	CcSEcCtD
Quetiapine—Nausea—Carbamazepine—epilepsy syndrome	7.12e-06	7.33e-05	CcSEcCtD
Quetiapine—Pain—Pregabalin—epilepsy syndrome	7.12e-06	7.33e-05	CcSEcCtD
Quetiapine—Constipation—Pregabalin—epilepsy syndrome	7.12e-06	7.33e-05	CcSEcCtD
Quetiapine—Malaise—Topiramate—epilepsy syndrome	7.1e-06	7.31e-05	CcSEcCtD
Quetiapine—Vertigo—Topiramate—epilepsy syndrome	7.07e-06	7.28e-05	CcSEcCtD
Quetiapine—Syncope—Topiramate—epilepsy syndrome	7.06e-06	7.27e-05	CcSEcCtD
Quetiapine—Leukopenia—Topiramate—epilepsy syndrome	7.05e-06	7.25e-05	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	6.96e-06	7.16e-05	CcSEcCtD
Quetiapine—Palpitations—Topiramate—epilepsy syndrome	6.96e-06	7.16e-05	CcSEcCtD
Quetiapine—Loss of consciousness—Topiramate—epilepsy syndrome	6.92e-06	7.12e-05	CcSEcCtD
Quetiapine—Insomnia—Gabapentin—epilepsy syndrome	6.91e-06	7.11e-05	CcSEcCtD
Quetiapine—Nausea—Lamotrigine—epilepsy syndrome	6.88e-06	7.09e-05	CcSEcCtD
Quetiapine—Trifluoperazine—ABCB1—epilepsy syndrome	6.88e-06	0.00369	CrCbGaD
Quetiapine—Cough—Topiramate—epilepsy syndrome	6.87e-06	7.07e-05	CcSEcCtD
Quetiapine—Feeling abnormal—Pregabalin—epilepsy syndrome	6.86e-06	7.06e-05	CcSEcCtD
Quetiapine—Paraesthesia—Gabapentin—epilepsy syndrome	6.86e-06	7.06e-05	CcSEcCtD
Quetiapine—Convulsion—Topiramate—epilepsy syndrome	6.82e-06	7.02e-05	CcSEcCtD
Quetiapine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	6.81e-06	7.01e-05	CcSEcCtD
Quetiapine—Dyspnoea—Gabapentin—epilepsy syndrome	6.81e-06	7.01e-05	CcSEcCtD
Quetiapine—Hypertension—Topiramate—epilepsy syndrome	6.8e-06	7e-05	CcSEcCtD
Quetiapine—Somnolence—Gabapentin—epilepsy syndrome	6.79e-06	6.99e-05	CcSEcCtD
Quetiapine—Hypersensitivity—Valproic Acid—epilepsy syndrome	6.79e-06	6.99e-05	CcSEcCtD
Quetiapine—Dyspepsia—Gabapentin—epilepsy syndrome	6.72e-06	6.92e-05	CcSEcCtD
Quetiapine—Myalgia—Topiramate—epilepsy syndrome	6.7e-06	6.9e-05	CcSEcCtD
Quetiapine—Arthralgia—Topiramate—epilepsy syndrome	6.7e-06	6.9e-05	CcSEcCtD
Quetiapine—Chest pain—Topiramate—epilepsy syndrome	6.7e-06	6.9e-05	CcSEcCtD
Quetiapine—Anxiety—Topiramate—epilepsy syndrome	6.68e-06	6.87e-05	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	6.65e-06	6.85e-05	CcSEcCtD
Quetiapine—Decreased appetite—Gabapentin—epilepsy syndrome	6.64e-06	6.83e-05	CcSEcCtD
Quetiapine—Discomfort—Topiramate—epilepsy syndrome	6.62e-06	6.82e-05	CcSEcCtD
Quetiapine—Asthenia—Valproic Acid—epilepsy syndrome	6.61e-06	6.8e-05	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	6.59e-06	6.79e-05	CcSEcCtD
Quetiapine—Fatigue—Gabapentin—epilepsy syndrome	6.58e-06	6.78e-05	CcSEcCtD
Quetiapine—Abdominal pain—Pregabalin—epilepsy syndrome	6.58e-06	6.78e-05	CcSEcCtD
Quetiapine—Body temperature increased—Pregabalin—epilepsy syndrome	6.58e-06	6.78e-05	CcSEcCtD
Quetiapine—Dry mouth—Topiramate—epilepsy syndrome	6.55e-06	6.75e-05	CcSEcCtD
Quetiapine—Pain—Gabapentin—epilepsy syndrome	6.53e-06	6.72e-05	CcSEcCtD
Quetiapine—Constipation—Gabapentin—epilepsy syndrome	6.53e-06	6.72e-05	CcSEcCtD
Quetiapine—Pruritus—Valproic Acid—epilepsy syndrome	6.52e-06	6.71e-05	CcSEcCtD
Quetiapine—Confusional state—Topiramate—epilepsy syndrome	6.48e-06	6.67e-05	CcSEcCtD
Quetiapine—Infection—Topiramate—epilepsy syndrome	6.38e-06	6.57e-05	CcSEcCtD
Quetiapine—Shock—Topiramate—epilepsy syndrome	6.32e-06	6.51e-05	CcSEcCtD
Quetiapine—Diarrhoea—Valproic Acid—epilepsy syndrome	6.3e-06	6.49e-05	CcSEcCtD
Quetiapine—Nervous system disorder—Topiramate—epilepsy syndrome	6.3e-06	6.48e-05	CcSEcCtD
Quetiapine—Feeling abnormal—Gabapentin—epilepsy syndrome	6.29e-06	6.48e-05	CcSEcCtD
Quetiapine—Thrombocytopenia—Topiramate—epilepsy syndrome	6.29e-06	6.47e-05	CcSEcCtD
Quetiapine—Tachycardia—Topiramate—epilepsy syndrome	6.27e-06	6.45e-05	CcSEcCtD
Quetiapine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	6.24e-06	6.43e-05	CcSEcCtD
Quetiapine—Skin disorder—Topiramate—epilepsy syndrome	6.24e-06	6.42e-05	CcSEcCtD
Quetiapine—Hyperhidrosis—Topiramate—epilepsy syndrome	6.21e-06	6.39e-05	CcSEcCtD
Quetiapine—Hypersensitivity—Pregabalin—epilepsy syndrome	6.13e-06	6.31e-05	CcSEcCtD
Quetiapine—Anorexia—Topiramate—epilepsy syndrome	6.12e-06	6.3e-05	CcSEcCtD
Quetiapine—Dizziness—Valproic Acid—epilepsy syndrome	6.09e-06	6.27e-05	CcSEcCtD
Quetiapine—Abdominal pain—Gabapentin—epilepsy syndrome	6.04e-06	6.21e-05	CcSEcCtD
Quetiapine—Body temperature increased—Gabapentin—epilepsy syndrome	6.04e-06	6.21e-05	CcSEcCtD
Quetiapine—Hypotension—Topiramate—epilepsy syndrome	6e-06	6.18e-05	CcSEcCtD
Quetiapine—Asthenia—Pregabalin—epilepsy syndrome	5.97e-06	6.15e-05	CcSEcCtD
Quetiapine—Pruritus—Pregabalin—epilepsy syndrome	5.89e-06	6.06e-05	CcSEcCtD
Quetiapine—Vomiting—Valproic Acid—epilepsy syndrome	5.86e-06	6.03e-05	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	5.85e-06	6.02e-05	CcSEcCtD
Quetiapine—Insomnia—Topiramate—epilepsy syndrome	5.81e-06	5.98e-05	CcSEcCtD
Quetiapine—Rash—Valproic Acid—epilepsy syndrome	5.81e-06	5.98e-05	CcSEcCtD
Quetiapine—Dermatitis—Valproic Acid—epilepsy syndrome	5.8e-06	5.97e-05	CcSEcCtD
Quetiapine—Headache—Valproic Acid—epilepsy syndrome	5.77e-06	5.94e-05	CcSEcCtD
Quetiapine—Paraesthesia—Topiramate—epilepsy syndrome	5.77e-06	5.94e-05	CcSEcCtD
Quetiapine—Clozapine—ABCB1—epilepsy syndrome	5.74e-06	0.00308	CrCbGaD
Quetiapine—Dyspnoea—Topiramate—epilepsy syndrome	5.73e-06	5.9e-05	CcSEcCtD
Quetiapine—Somnolence—Topiramate—epilepsy syndrome	5.71e-06	5.88e-05	CcSEcCtD
Quetiapine—Diarrhoea—Pregabalin—epilepsy syndrome	5.7e-06	5.86e-05	CcSEcCtD
Quetiapine—Dyspepsia—Topiramate—epilepsy syndrome	5.65e-06	5.82e-05	CcSEcCtD
Quetiapine—Hypersensitivity—Gabapentin—epilepsy syndrome	5.63e-06	5.79e-05	CcSEcCtD
Quetiapine—Decreased appetite—Topiramate—epilepsy syndrome	5.58e-06	5.75e-05	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.55e-06	5.71e-05	CcSEcCtD
Quetiapine—Fatigue—Topiramate—epilepsy syndrome	5.54e-06	5.7e-05	CcSEcCtD
Quetiapine—Dizziness—Pregabalin—epilepsy syndrome	5.51e-06	5.67e-05	CcSEcCtD
Quetiapine—Constipation—Topiramate—epilepsy syndrome	5.49e-06	5.65e-05	CcSEcCtD
Quetiapine—Pain—Topiramate—epilepsy syndrome	5.49e-06	5.65e-05	CcSEcCtD
Quetiapine—Asthenia—Gabapentin—epilepsy syndrome	5.48e-06	5.64e-05	CcSEcCtD
Quetiapine—Nausea—Valproic Acid—epilepsy syndrome	5.47e-06	5.63e-05	CcSEcCtD
Quetiapine—Pruritus—Gabapentin—epilepsy syndrome	5.4e-06	5.56e-05	CcSEcCtD
Quetiapine—Vomiting—Pregabalin—epilepsy syndrome	5.29e-06	5.45e-05	CcSEcCtD
Quetiapine—Feeling abnormal—Topiramate—epilepsy syndrome	5.29e-06	5.45e-05	CcSEcCtD
Quetiapine—Gastrointestinal pain—Topiramate—epilepsy syndrome	5.25e-06	5.41e-05	CcSEcCtD
Quetiapine—Rash—Pregabalin—epilepsy syndrome	5.25e-06	5.4e-05	CcSEcCtD
Quetiapine—Dermatitis—Pregabalin—epilepsy syndrome	5.25e-06	5.4e-05	CcSEcCtD
Quetiapine—Diarrhoea—Gabapentin—epilepsy syndrome	5.22e-06	5.38e-05	CcSEcCtD
Quetiapine—Headache—Pregabalin—epilepsy syndrome	5.22e-06	5.37e-05	CcSEcCtD
Quetiapine—Abdominal pain—Topiramate—epilepsy syndrome	5.08e-06	5.23e-05	CcSEcCtD
Quetiapine—Body temperature increased—Topiramate—epilepsy syndrome	5.08e-06	5.23e-05	CcSEcCtD
Quetiapine—Dizziness—Gabapentin—epilepsy syndrome	5.05e-06	5.2e-05	CcSEcCtD
Quetiapine—Nausea—Pregabalin—epilepsy syndrome	4.95e-06	5.09e-05	CcSEcCtD
Quetiapine—Vomiting—Gabapentin—epilepsy syndrome	4.85e-06	5e-05	CcSEcCtD
Quetiapine—Rash—Gabapentin—epilepsy syndrome	4.81e-06	4.96e-05	CcSEcCtD
Quetiapine—Dermatitis—Gabapentin—epilepsy syndrome	4.81e-06	4.95e-05	CcSEcCtD
Quetiapine—Headache—Gabapentin—epilepsy syndrome	4.78e-06	4.92e-05	CcSEcCtD
Quetiapine—Hypersensitivity—Topiramate—epilepsy syndrome	4.73e-06	4.87e-05	CcSEcCtD
Quetiapine—Asthenia—Topiramate—epilepsy syndrome	4.61e-06	4.74e-05	CcSEcCtD
Quetiapine—Pruritus—Topiramate—epilepsy syndrome	4.54e-06	4.68e-05	CcSEcCtD
Quetiapine—Nausea—Gabapentin—epilepsy syndrome	4.54e-06	4.67e-05	CcSEcCtD
Quetiapine—Diarrhoea—Topiramate—epilepsy syndrome	4.4e-06	4.52e-05	CcSEcCtD
Quetiapine—Dizziness—Topiramate—epilepsy syndrome	4.25e-06	4.37e-05	CcSEcCtD
Quetiapine—Vomiting—Topiramate—epilepsy syndrome	4.08e-06	4.2e-05	CcSEcCtD
Quetiapine—Rash—Topiramate—epilepsy syndrome	4.05e-06	4.17e-05	CcSEcCtD
Quetiapine—Dermatitis—Topiramate—epilepsy syndrome	4.05e-06	4.17e-05	CcSEcCtD
Quetiapine—Headache—Topiramate—epilepsy syndrome	4.02e-06	4.14e-05	CcSEcCtD
Quetiapine—Nausea—Topiramate—epilepsy syndrome	3.82e-06	3.93e-05	CcSEcCtD
Quetiapine—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	3.88e-07	6.9e-06	CbGpPWpGaD
Quetiapine—CHRM4—Signaling by GPCR—AKT1—epilepsy syndrome	3.88e-07	6.9e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	3.87e-07	6.89e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	3.87e-07	6.88e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—POMC—epilepsy syndrome	3.87e-07	6.87e-06	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—POMC—epilepsy syndrome	3.86e-07	6.87e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—CASP3—epilepsy syndrome	3.86e-07	6.87e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	3.85e-07	6.85e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	3.85e-07	6.85e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	3.85e-07	6.85e-06	CbGpPWpGaD
Quetiapine—DRD3—GPCR downstream signaling—AKT1—epilepsy syndrome	3.85e-07	6.84e-06	CbGpPWpGaD
Quetiapine—ADRA1D—GPCR downstream signaling—AKT1—epilepsy syndrome	3.85e-07	6.84e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—ALB—epilepsy syndrome	3.84e-07	6.83e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	3.84e-07	6.83e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	3.84e-07	6.82e-06	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—MMP9—epilepsy syndrome	3.83e-07	6.81e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	3.81e-07	6.78e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—CASP3—epilepsy syndrome	3.81e-07	6.77e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—CASP3—epilepsy syndrome	3.81e-07	6.77e-06	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—VEGFA—epilepsy syndrome	3.81e-07	6.77e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	3.8e-07	6.76e-06	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—VEGFA—epilepsy syndrome	3.8e-07	6.76e-06	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	3.8e-07	6.75e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	3.79e-07	6.75e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	3.79e-07	6.74e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	3.78e-07	6.73e-06	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	3.78e-07	6.72e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	3.78e-07	6.72e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	3.77e-07	6.7e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	3.76e-07	6.68e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—JUN—epilepsy syndrome	3.75e-07	6.67e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	3.74e-07	6.65e-06	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—SRC—epilepsy syndrome	3.74e-07	6.64e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	3.72e-07	6.62e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	3.72e-07	6.62e-06	CbGpPWpGaD
Quetiapine—CHRM5—Signaling by GPCR—AKT1—epilepsy syndrome	3.71e-07	6.6e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	3.71e-07	6.6e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—JUN—epilepsy syndrome	3.7e-07	6.58e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—JUN—epilepsy syndrome	3.7e-07	6.58e-06	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	3.7e-07	6.58e-06	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—SRC—epilepsy syndrome	3.69e-07	6.56e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	3.68e-07	6.55e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.67e-07	6.52e-06	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PTGS2—epilepsy syndrome	3.66e-07	6.52e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	3.66e-07	6.51e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—MMP9—epilepsy syndrome	3.65e-07	6.49e-06	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—VEGFA—epilepsy syndrome	3.64e-07	6.47e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	3.61e-07	6.42e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—MMP9—epilepsy syndrome	3.6e-07	6.4e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—MMP9—epilepsy syndrome	3.6e-07	6.4e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	3.59e-07	6.39e-06	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—VEGFA—epilepsy syndrome	3.59e-07	6.38e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	3.56e-07	6.33e-06	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—AKT1—epilepsy syndrome	3.56e-07	6.32e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—AGT—epilepsy syndrome	3.55e-07	6.31e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling by GPCR—AKT1—epilepsy syndrome	3.54e-07	6.29e-06	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—SRC—epilepsy syndrome	3.53e-07	6.28e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	3.53e-07	6.27e-06	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—ALB—epilepsy syndrome	3.52e-07	6.26e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	3.51e-07	6.23e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	3.49e-07	6.21e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—AKT1—epilepsy syndrome	3.49e-07	6.21e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—AKT1—epilepsy syndrome	3.49e-07	6.21e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.49e-07	6.2e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	3.48e-07	6.19e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—APOE—epilepsy syndrome	3.48e-07	6.18e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.48e-07	6.18e-06	CbGpPWpGaD
Quetiapine—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	3.47e-07	6.17e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—AGT—epilepsy syndrome	3.46e-07	6.16e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	3.45e-07	6.13e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	3.44e-07	6.12e-06	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—VEGFA—epilepsy syndrome	3.44e-07	6.11e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	3.44e-07	6.11e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	3.43e-07	6.09e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	3.42e-07	6.08e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	3.41e-07	6.06e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	3.4e-07	6.04e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—APOE—epilepsy syndrome	3.39e-07	6.03e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—SRC—epilepsy syndrome	3.36e-07	5.98e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	3.36e-07	5.98e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	3.36e-07	5.98e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	3.36e-07	5.96e-06	CbGpPWpGaD
Quetiapine—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.35e-07	5.96e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	3.34e-07	5.94e-06	CbGpPWpGaD
Quetiapine—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	3.33e-07	5.93e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	3.32e-07	5.9e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—SRC—epilepsy syndrome	3.32e-07	5.9e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—SRC—epilepsy syndrome	3.32e-07	5.9e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.32e-07	5.89e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	3.3e-07	5.87e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.28e-07	5.83e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—VEGFA—epilepsy syndrome	3.28e-07	5.83e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—TH—epilepsy syndrome	3.27e-07	5.81e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—AGT—epilepsy syndrome	3.26e-07	5.8e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	3.25e-07	5.78e-06	CbGpPWpGaD
Quetiapine—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	3.24e-07	5.77e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—VEGFA—epilepsy syndrome	3.23e-07	5.75e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—VEGFA—epilepsy syndrome	3.23e-07	5.75e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—RELA—epilepsy syndrome	3.23e-07	5.75e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	3.23e-07	5.73e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	3.21e-07	5.71e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	3.21e-07	5.71e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—APOE—epilepsy syndrome	3.2e-07	5.69e-06	CbGpPWpGaD
Quetiapine—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	3.19e-07	5.67e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	3.18e-07	5.65e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—RELA—epilepsy syndrome	3.17e-07	5.64e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	3.17e-07	5.64e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	3.16e-07	5.62e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	3.16e-07	5.62e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	3.15e-07	5.61e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	3.15e-07	5.61e-06	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—AKT1—epilepsy syndrome	3.15e-07	5.59e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	3.14e-07	5.58e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	3.12e-07	5.55e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	3.12e-07	5.55e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	3.12e-07	5.55e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	3.12e-07	5.55e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	3.12e-07	5.54e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	3.11e-07	5.54e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	3.11e-07	5.53e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	3.1e-07	5.52e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	3.09e-07	5.5e-06	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	3.08e-07	5.48e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	3.07e-07	5.46e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	3.06e-07	5.44e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	3.05e-07	5.43e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	3.04e-07	5.41e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	3.04e-07	5.4e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	3.03e-07	5.38e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	3e-07	5.33e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	2.99e-07	5.31e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—POMC—epilepsy syndrome	2.99e-07	5.31e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	2.95e-07	5.24e-06	CbGpPWpGaD
Quetiapine—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.94e-07	5.23e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	2.92e-07	5.19e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	2.92e-07	5.18e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—POMC—epilepsy syndrome	2.92e-07	5.18e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	2.9e-07	5.15e-06	CbGpPWpGaD
Quetiapine—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.9e-07	5.15e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	2.89e-07	5.14e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	2.89e-07	5.14e-06	CbGpPWpGaD
Quetiapine—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.89e-07	5.14e-06	CbGpPWpGaD
Quetiapine—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.88e-07	5.12e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	2.88e-07	5.12e-06	CbGpPWpGaD
Quetiapine—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	2.87e-07	5.1e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	2.87e-07	5.1e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	2.86e-07	5.09e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	2.85e-07	5.07e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	2.84e-07	5.06e-06	CbGpPWpGaD
Quetiapine—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.84e-07	5.05e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	2.84e-07	5.05e-06	CbGpPWpGaD
Quetiapine—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.84e-07	5.04e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—JUN—epilepsy syndrome	2.83e-07	5.03e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	2.82e-07	5.01e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	2.82e-07	5.01e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	2.81e-07	4.99e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	2.8e-07	4.98e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	2.8e-07	4.98e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	2.79e-07	4.95e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—JUN—epilepsy syndrome	2.78e-07	4.94e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	2.77e-07	4.93e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	2.76e-07	4.91e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	2.76e-07	4.9e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	2.76e-07	4.9e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—POMC—epilepsy syndrome	2.75e-07	4.88e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	2.74e-07	4.86e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	2.73e-07	4.85e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.73e-07	4.85e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	2.73e-07	4.85e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—ALB—epilepsy syndrome	2.72e-07	4.84e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	2.71e-07	4.82e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	2.71e-07	4.81e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	2.7e-07	4.79e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.69e-07	4.78e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	2.69e-07	4.78e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	2.68e-07	4.77e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	2.67e-07	4.75e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	2.66e-07	4.73e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—ALB—epilepsy syndrome	2.66e-07	4.73e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	2.65e-07	4.72e-06	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.63e-07	4.68e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	2.63e-07	4.67e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	2.62e-07	4.66e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.62e-07	4.65e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	2.62e-07	4.65e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	2.61e-07	4.64e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	2.61e-07	4.63e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	2.58e-07	4.59e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	2.57e-07	4.58e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—SRC—epilepsy syndrome	2.54e-07	4.52e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	2.54e-07	4.51e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—ALB—epilepsy syndrome	2.5e-07	4.45e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	2.5e-07	4.44e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—SRC—epilepsy syndrome	2.49e-07	4.43e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	2.49e-07	4.42e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	2.48e-07	4.41e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	2.47e-07	4.4e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	2.47e-07	4.39e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	2.45e-07	4.36e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	2.45e-07	4.35e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	2.43e-07	4.33e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.43e-07	4.33e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	2.43e-07	4.32e-06	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—AKT1—epilepsy syndrome	2.43e-07	4.32e-06	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—AKT1—epilepsy syndrome	2.43e-07	4.31e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	2.42e-07	4.3e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	2.41e-07	4.29e-06	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	2.41e-07	4.29e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	2.39e-07	4.25e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	2.39e-07	4.25e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	2.38e-07	4.24e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	2.38e-07	4.24e-06	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	2.36e-07	4.2e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTGS2—epilepsy syndrome	2.33e-07	4.13e-06	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—AKT1—epilepsy syndrome	2.32e-07	4.13e-06	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—AKT1—epilepsy syndrome	2.29e-07	4.07e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	2.27e-07	4.04e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	2.21e-07	3.94e-06	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—AKT1—epilepsy syndrome	2.19e-07	3.9e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	2.19e-07	3.9e-06	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—AKT1—epilepsy syndrome	2.14e-07	3.81e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.13e-07	3.79e-06	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—AKT1—epilepsy syndrome	2.09e-07	3.72e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.09e-07	3.72e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—AKT1—epilepsy syndrome	2.08e-07	3.7e-06	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—AKT1—epilepsy syndrome	2.06e-07	3.67e-06	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—AKT1—epilepsy syndrome	2.06e-07	3.67e-06	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	1.86e-07	3.31e-06	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—AKT1—epilepsy syndrome	1.84e-07	3.27e-06	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	1.8e-07	3.2e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.8e-07	3.19e-06	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	1.79e-07	3.18e-06	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	1.74e-07	3.09e-06	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	1.71e-07	3.04e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—AKT1—epilepsy syndrome	1.69e-07	3e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.64e-07	2.91e-06	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	1.58e-07	2.81e-06	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	1.55e-07	2.76e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	1.55e-07	2.76e-06	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—AKT1—epilepsy syndrome	1.55e-07	2.75e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.55e-07	2.75e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	1.54e-07	2.74e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	1.53e-07	2.71e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	1.52e-07	2.7e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.43e-07	2.55e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	1.41e-07	2.51e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—AKT1—epilepsy syndrome	1.2e-07	2.13e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.17e-07	2.08e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.1e-07	1.96e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	7.2e-08	1.28e-06	CbGpPWpGaD
